IC
TARO

ISZO Capital’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

ISZO Capital’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$105M Buy
+1,104,068
New +$95.8M 77.66% 1

Other funds holding TARO

AIM
Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
GCM
Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
VCAM
Valentine Capital Asset Management Danville, California $89.6M AUM 0.84% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ISZO Capital's TARO Position: Q4 2013 in Review

ISZO Capital opened a new position in Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2013: 1,104,068 shares worth $105M. The stake represents 77.66% of the portfolio and ranks #1 among its holdings.

55 funds tracked by Wall St. Rank hold TARO as of Q4 2013.

  • ISZO Capital held 1,104,068 shares of Taro Pharmaceutical Industries Ltd. worth $105M as of Q4 2013.
  • Taro Pharmaceutical Industries Ltd. was a new ISZO Capital position in Q4 2013.
  • Taro Pharmaceutical Industries Ltd. made up 77.66% of ISZO Capital's portfolio in Q4 2013, its #1 holding.
  • 55 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2013.

Based on ISZO Capital's 13F filing for Q4 2013, filed 14 Feb 2014.